Skip to content

Perioperative management of remimazolam for general anesthesia and the effect on patient prognosis

Perioperative management of remimazolam for general anesthesia and the impact on patient prognosis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064255
Enrollment
Unknown
Registered
2022-10-01
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia

Interventions

Control group:Normal saline

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. ASA I-III objects; 2. Participants are older than 18 years. 3. 18 <= BMI <= 29.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to experimental drugs or have other contraindications; 2. With serious heart, lung, liver, kidney and brain diseases; 3. Severe blood system dysfunction; 4. Patients with history of mental disorders, chronic pain, or abnormal pain perception; 5. Recent history of pain, including surgery and trauma; 6. Long-term use of sedative analgesics or dependence on sedative analgesics patients, alcoholism patients; 7. Pregnant and lactating women; 8. For other reasons, they were not considered suitable subjects for study.

Design outcomes

Primary

MeasureTime frame
cognitive impairment;

Secondary

MeasureTime frame
pain score;Postoperative analgesic drug use;Adverse events;Inflammatory factors;stress level;Dosage of propofol;Temperature change;Change in anxiety level;BIS level;Hemodynamic fluctuations;Use of vasoactive drugs;Hyperalgesia level;Ramsay sedation score;awakening time;Extubation time;Sleep rhythm;Remifentanil dosage;qCON and qNOX;QoR-15 score;Patient and investigator satisfaction;zinc level;

Countries

China

Contacts

Public ContactLi Yize

Tianjin Medical University General Hospital

liyizelisa@126.com+86 13512224465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026